Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/2006
01/03/2006CA2132297C Pyrido[2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors
01/03/2006CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids
01/01/2006CA2502425A1 Allergen from house-dust mites
12/2005
12/29/2005WO2005123745A1 Tricyclic compounds
12/29/2005WO2005123741A1 Alkyl substituted indoloquinoxalines
12/29/2005WO2005123697A1 Quinazoline derivatives
12/29/2005WO2005123677A1 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
12/29/2005WO2005123671A1 Pyrrole derivative
12/29/2005WO2005123128A2 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005WO2005123107A2 Immune response suppressor and treatment of multiple sclerosis
12/29/2005WO2005123065A1 Chemokine receptor antagonistic medicinal composition
12/29/2005WO2005123058A1 Antiaging agent
12/29/2005WO2005012294A8 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
12/29/2005WO2004094599A3 Disease prevention and vaccination following thymic reactivation
12/29/2005WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer
12/29/2005US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
12/29/2005US20050288487 Human mast cell-expressed membrane proteins
12/29/2005US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
12/29/2005US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent
12/29/2005US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
12/29/2005US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
12/29/2005US20050288337 Novel compounds
12/29/2005US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
12/29/2005US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates
12/29/2005US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
12/29/2005US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288296 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases
12/29/2005US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005US20050288274 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane
12/29/2005US20050288265 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copd
12/29/2005US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine.
12/29/2005US20050288237 Novel derivative of flavone c-glycoside and composition containing the same
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050287647 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/29/2005US20050287642 Efficient protein expression system
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287603 Modulation of bone development
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287521 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
12/29/2005US20050287232 Skin immune function controlling agents
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287163 Mycoplasma polypeptides
12/29/2005US20050287162 Recombinant fowlpox virus
12/29/2005US20050287159 Treatment methods for eotaxin mediated inflammatory conditons
12/29/2005US20050287157 Dry formulation for transcutaneous immunization
12/29/2005US20050287148 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005CA2847677A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005CA2573144A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005CA2569697A1 A pharmaceutical composition and its use
12/29/2005CA2568384A1 Immune response suppressor and treatment of multiple sclerosis
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609860A1 Seb modification and preventive/remedy for diseases with immune abnormality contianing the same
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1608730A2 Truncated baff receptors
12/28/2005EP1608651A1 Protein kinase inhibitors
12/28/2005EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/28/2005EP1608403A2 Immunostimulatory nucleic acid oil-in-water formulations for topical application
12/28/2005EP1608387A2 ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAININGw3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF
12/28/2005EP1608368A1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608316A2 Methods and compositions for treating and preventing inflammatory conditions
12/28/2005EP1608310A2 Methods and compositions for blocking the calcium cascade
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1335987B1 Modified vaccinia ankara virus variant
12/28/2005EP1274454B1 Methods and compositions for eliciting an immune response
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1085909B1 A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005CN1714153A Recombinant protein variants
12/28/2005CN1714136A Composition containing high oxygen stabilized double bonded organic compound
12/28/2005CN1714135A External composition containing highly unsaturated fatty acid or its salt or ester
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713912A Use of levocetirizine for the treatment of persistent allergic rhinitis
12/28/2005CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233413C Nano particle feeding system for oral use
12/28/2005CN1233328C Cell growth regulating factor K and its preparation process
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979672 Cyclosporin-based pharmaceutical compositions
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
1 ... 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 ... 1172